It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

2025 is going to be a year of great change. At a macro level, political and geopolitical shifts around the world will reshape ...

The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and ...

The UK government has launched a £150 million ($185 million) procurement drive for artificial intelligence solutions that can ...

The INTERCEPT study is being funded to the tune of €38 million (nearly $40 million) over the next five years and is described ...

A collaboration between data scientists, clinical researchers, and community opticians in the UK is hoping to develop an ...

The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

Trump has so far not targeted any of Biden's signature healthcare policies, including Medicare drug pricing negotiation ...

At the conference last week in San Francisco, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO Marianne De Backer, who explained a bit more about what a dual-masked T-cell ...

The recent wave of AI innovation has fallen short of transforming commercial life sciences. In 2025, European biopharmas that ...

One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with ...